首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1916086

2025-2029年全球全外EXOME定序市場

Global Whole Exome Sequencing Market 2025-2029

出版日期: 2026年01月19日 | 出版商:

TechNavio | 英文 299 Pages | 訂單完成後即時交付

價格

簡介目錄

全球全EXOME定序市場預計在2024年至2029年間成長37.428億美元，預測期內複合年成長率（CAGR）為21.1%。本報告對全球全外EXOME定序市場進行了全面分析，包括市場規模和預測、趨勢、成長要素和挑戰，以及對約25家公司的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。市場發展的驅動力包括技術進步和定序成本的快速下降、臨床效用的擴大和與標準診斷工作流程的整合，以及政府和私人機構大規模精準醫療舉措的激增。

本研究採用客觀的方法，結合一手和二手訊息，包括來自主要行業相關人員的意見。報告包含全面的市場規模數據、區域細分分析、供應商格局以及對主要企業的分析。報告提供歷史數據和預測數據。

市場覆蓋範圍
基準年	2025
目標期	2029
預測期	2025-2029
成長勢頭	加速度
同比	20.6%
複合年成長率	21.1%
增量	37.428億美元

研究指出，人工智慧和機器學習的融合，尤其是加速變異解讀，是未來幾年推動全球全EXOME序市場成長的關鍵因素之一。此外，全EXOME序在人群健康舉措和主流臨床實踐中的廣泛應用，以及用於高階EXOME表徵的長讀長定序技術的興起，預計也將顯著提升市場需求。

區域細分
區域比較
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 義大利
- 荷蘭
- 西班牙
- 俄羅斯
亞洲
- 中國
- 日本
- 印度
- 韓國
- 印尼
- 泰國
- 新加坡
世界其他地區
- 澳洲
- 巴西
- 阿拉伯聯合大公國
- 南非
- 沙烏地阿拉伯
- 土耳其
各區域的市場機遇

第12章：促進因素、挑戰與機遇

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機遇

第13章競爭格局

概述
競爭格局
令人困惑的局面
產業風險

第14章競爭分析

公司簡介
企業排名指數
公司市場定位
Agilent Technologies Inc.
Ambry Genetics
Azenta US Inc.
BGI Genomics Co. Ltd.
CD Genomics
Eurofins Scientific SE
F. Hoffmann La Roche Ltd.
Illumina Inc.
Macrogen Inc.
Novogene Co. Ltd.
Oxford Nanopore Technologies plc
Pacific Biosciences of California Inc.
Psomagen Inc.
QIAGEN NV
Thermo Fisher Scientific Inc.

第15章附錄

簡介目錄

Product Code: IRTNTR81135

The global whole exome sequencing market is forecasted to grow by USD 3742.8 mn during 2024-2029, accelerating at a CAGR of 21.1% during the forecast period. The report on the global whole exome sequencing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements and precipitous decline in sequencing costs, expanding clinical utility and integration into standard diagnostic workflows, proliferation of large scale government and private precision medicine initiatives.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	20.6%
CAGR	21.1%
Incremental Value	$3742.8 mn

Technavio's global whole exome sequencing market is segmented as below:

By Product

Consumables
Services
Instruments

By Technology

Sequencing by synthesis
ION semiconductor sequencing
Others

By Application

Drug discovery and development
Diagnostics
Personalized medicine
Prenatal and neonatal screening
Others

Geography

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- The Netherlands
- Spain
- Russia
Asia
Rest of World (ROW)
Rest of World (ROW)

This study identifies the integration of artificial intelligence and machine learning for accelerated variant interpretation as one of the prime reasons driving the global whole exome sequencing market growth during the next few years. Also, proliferation of whole exome sequencing in population health initiatives and mainstream clinical practice and ascendancy of long read sequencing technologies for enhanced exome characterization will lead to sizable demand in the market.

The report on the global whole exome sequencing market covers the following areas:

Global whole exome sequencing market sizing
Global whole exome sequencing market forecast
Global whole exome sequencing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global whole exome sequencing market vendors that include Agilent Technologies Inc., Ambry Genetics, Azenta US Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., CD Genomics, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., GeneDx LLC, Illumina Inc., Laboratory Corp., Macrogen Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., PerkinElmer US LLC, ProPhase Labs, Inc., Psomagen Inc., QIAGEN N.V., Thermo Fisher Scientific Inc.. Also, the global whole exome sequencing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

5.1 Global Whole Exome Sequencing Market 2019 - 2023
- Historic Market Size - Data Table on Global Whole Exome Sequencing Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Technology segment analysis 2019 - 2023
- Historic Market Size - Technology Segment 2019 - 2023 ($ million)
5.4 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Five Forces Analysis

6.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
6.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
6.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
6.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
6.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
6.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
6.7 Market condition

7 Market Segmentation by Product

7.1 Market segments
7.2 Comparison by Product
7.3 Consumables - Market size and forecast 2024-2029
7.4 Services - Market size and forecast 2024-2029
7.5 Instruments - Market size and forecast 2024-2029
7.6 Market opportunity by Product
- Market opportunity by Product ($ million)

8 Market Segmentation by Technology

8.1 Market segments
8.2 Comparison by Technology
8.3 Sequencing by synthesis - Market size and forecast 2024-2029
8.4 ION semiconductor sequencing - Market size and forecast 2024-2029
8.5 Others - Market size and forecast 2024-2029
8.6 Market opportunity by Technology
- Market opportunity by Technology ($ million)

9 Market Segmentation by Application

9.1 Market segments
9.2 Comparison by Application
9.3 Drug discovery and development - Market size and forecast 2024-2029
9.4 Diagnostics - Market size and forecast 2024-2029
9.5 Personalized medicine - Market size and forecast 2024-2029
9.6 Prenatal and neonatal screening - Market size and forecast 2024-2029
9.7 Others - Market size and forecast 2024-2029
9.8 Market opportunity by Application
- Market opportunity by Application ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
11.2 Geographic comparison
11.3 North America - Market size and forecast 2024-2029
- 11.3.1 US - Market size and forecast 2024-2029
- 11.3.2 Canada - Market size and forecast 2024-2029
- 11.3.3 Mexico - Market size and forecast 2024-2029
11.4 Europe - Market size and forecast 2024-2029
- 11.4.1 Germany - Market size and forecast 2024-2029
- 11.4.2 UK - Market size and forecast 2024-2029
- 11.4.3 France - Market size and forecast 2024-2029
- 11.4.4 Italy - Market size and forecast 2024-2029
- 11.4.5 The Netherlands - Market size and forecast 2024-2029
- 11.4.6 Spain - Market size and forecast 2024-2029
- 11.4.7 Russia - Market size and forecast 2024-2029
11.5 Asia - Market size and forecast 2024-2029
- 11.5.1 China - Market size and forecast 2024-2029
- 11.5.2 Japan - Market size and forecast 2024-2029
- 11.5.3 India - Market size and forecast 2024-2029
- 11.5.4 South Korea - Market size and forecast 2024-2029
- 11.5.5 Indonesia - Market size and forecast 2024-2029
- 11.5.6 Thailand - Market size and forecast 2024-2029
- 11.5.7 Singapore - Market size and forecast 2024-2029
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- 11.6.1 Australia - Market size and forecast 2024-2029
- 11.6.2 Brazil - Market size and forecast 2024-2029
- 11.6.3 UAE - Market size and forecast 2024-2029
- 11.6.4 South Africa - Market size and forecast 2024-2029
- 11.6.5 Saudi Arabia - Market size and forecast 2024-2029
- 11.6.6 Turkey - Market size and forecast 2024-2029
11.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

12 Drivers, Challenges, and Opportunity

12.1 Market drivers
- Technological advancements and precipitous decline in sequencing costs
- Expanding clinical utility and integration into standard diagnostic workflows
- Proliferation of large scale government and private precision medicine initiatives
12.2 Market challenges
- Bioinformatics bottleneck and complexity of data interpretation
- Inconsistent reimbursement policies and evolving regulatory landscapes
- Ethical, legal, and social implications (ELSI) surrounding data privacy and consent
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities
- Integration of artificial intelligence and machine learning for accelerated variant interpretation
- Proliferation of whole exome sequencing in population health initiatives and mainstream clinical practice
- Ascendancy of long read sequencing technologies for enhanced exome characterization

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
14.5 Ambry Genetics
- Ambry Genetics - Overview
- Ambry Genetics - Product / Service
- Ambry Genetics - Key offerings
- SWOT
14.6 Azenta US Inc.
- Azenta US Inc. - Overview
- Azenta US Inc. - Business segments
- Azenta US Inc. - Key news
- Azenta US Inc. - Key offerings
- Azenta US Inc. - Segment focus
- SWOT
14.7 BGI Genomics Co. Ltd.
- BGI Genomics Co. Ltd. - Overview
- BGI Genomics Co. Ltd. - Product / Service
- BGI Genomics Co. Ltd. - Key offerings
- SWOT
14.8 CD Genomics
- CD Genomics - Overview
- CD Genomics - Product / Service
- CD Genomics - Key offerings
- SWOT
14.9 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
14.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
14.11 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
14.12 Macrogen Inc.
- Macrogen Inc. - Overview
- Macrogen Inc. - Product / Service
- Macrogen Inc. - Key offerings
- SWOT
14.13 Novogene Co. Ltd.
- Novogene Co. Ltd. - Overview
- Novogene Co. Ltd. - Product / Service
- Novogene Co. Ltd. - Key offerings
- SWOT
14.14 Oxford Nanopore Technologies plc
- Oxford Nanopore Technologies plc - Overview
- Oxford Nanopore Technologies plc - Product / Service
- Oxford Nanopore Technologies plc - Key offerings
- SWOT
14.15 Pacific Biosciences of California Inc.
- Pacific Biosciences of California Inc. - Overview
- Pacific Biosciences of California Inc. - Product / Service
- Pacific Biosciences of California Inc. - Key news
- Pacific Biosciences of California Inc. - Key offerings
- SWOT
14.16 Psomagen Inc.
- Psomagen Inc. - Overview
- Psomagen Inc. - Product / Service
- Psomagen Inc. - Key offerings
- SWOT
14.17 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key news
- QIAGEN N.V. - Key offerings
- SWOT
14.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT

15 Appendix

15.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations